Non-Hodgkin B-cell MALT lymphoma of marginal zone of the upper eyelid

Authors

  • Nataliia Malachkova National Pirogov Memorial Medical University, Vinnytsya https://orcid.org/0000-0002-7899-379X
  • Yevgeniia Prus Optimal-M LLC
  • S.O. Magdebura Podilsky regional center of oncology

Keywords:

orbit, non-Hodgkin’s lymphoma, oncologist, brain, biopsy

Abstract

http://doi.org/10.31288/oftalmolzh202256570

УДК  617.77-006.441

Background: Non-Hodgkin lymphoma (NHL) represents a heterogenous group of malignant lymphoproliferative neoplasms originating from lymphoid tissue cells and having distinct clinical, cytomorphological, immunological and molecular and genetic features. Primary orbital lymphomas are rare and account for approximately 1% of all NHL. Lymphomas are, however, the most common primary orbital tumor in adults 60 years of age and older.

Purpose: To present a rare case of primary B-cell MALT lymphoma of marginal zone of the upper eyelid, to highlight its clinical features, and to demonstrate the importance of a multidisciplinary approach to its treatment.

Results: A male patient presented to the eye clinic complaining of bilateral pterygium and periodic nasal congestion. Within the course of examination and prolonged observation, the ophthalmologist suspected the symptoms of massive orbital disease, and the patient was referred for magnetic resonance imaging (MRI) of the brain. On the basis of imaging assessment and the oncologist’s opinion, the patient was hospitalized at the Podillia Regional Oncology Center with a preliminary diagnosis of orbital lymphoma. Thereat, a final diagnosis of “extranodal, non-Hodgkin’s B-cell lymphoma of the marginal zone (MALT lymphoma) of Stage 3a, with metastases in the lungs, pleura and lymph nodes of the mediastinum” was established. At the moment, he is under observation by an oncologist and on the way to stabilization of his major disease.

Conclusion: Management of orbital non-Hodgkin’s lymphomas remains a challenge requiring a multidisciplinary approach involving ophthalmologists and oncologists.

References

Чиссов ВИ, Дарьялова СЛ. редакторы. Руководство по онкологии. Москва, 2008.

Ahmed S, Shahid RK, Sison CP, Fuchs A, Mehrotra B. Orbital lymphomas: a clinicopathologic study of a rare disease. AmJMedSci. 2006; 331: 79–83.

Demirci H, Shields CL, Shields JA, Honavar SG, Mercado GJ, Tovilla JC. Orbital tumors in the older adult population. Ophthalmology. 2002; 109: 243–248.

Isaacson PG, Wright DH. Malignant lymphoma of mucosal associated lymphoid tissue: a distinctive type of B cell lymphoma. Cancer. 1983; 52: 1410–1416.

Ishii Y, Tomita N, Takasi H, Ogusa E, Hattori Y, Matsuura S, Matsumoto C, Takemura S, Kuwabara H, Ishigatsubo Y. Clinical features of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue. Hematol Oncol. 2012; 30: 186–189.

Поддубная ИВ, Москаленко ОА, Балакирева ЮН. Неходжкинские лимфомы маргинальной зоны. Современная онкология. 2006; 1 (8): 8-13.

Козарезова ТИ, Климкович НН. Болезни крови у детей. Учебное пособие. Минск: Белорусская наука, 2001. 383 с.

Гришина ЕЕ. Злокачественные лимфомы органа зрения. Проблемы и перспективы (взгляд офтальмолога).Современная онкология. 2006; 8(4): 27-29.

Coupland S., Krause L., Delecluse H. et al. Lymphoproliferative disorders of the ocular adnexa. Analysis of 112 cases. Ophthalmology. 1998; 105(8): 1430-1441.

Cahill M, Barnes C, Moriarty P. et al. Ocular adnexal lymphoma– comparison of I MALT lymphoma with other histological types. Br . J.Ophthalmol. 1999; 83: 742–747.

Nakata M., Matsuno Y., Katsumata N. et al. Histology according to the Revised European–American Lymphoma classification significantly predicts the prognosis of ocular adnexal lymphoma. Leuk–Lymphoma. 1999; 32(5–6): 533–543.

Knowles DM, Jacobiec FA, McNally L, Burke J. Lymphoid hyperplasia and malignant lymphoma occurring in the ocular adnexa (orbit, conjinctiva and eyelids): a prospective multiparametric analysis of 108 cases during 1977 to 1987. 7 Hum–Pathol. 1990; 21 (9): 959–973.

Meunier J, Lumbroso-Le Rouich, Dendale R et al. Conjunctival low–grade non–Hodgkin’s lymphoma. Leuc Lymphoma. 2006 Jul; 47 (7): 1295–1305.

Khalil HA, de Keiser RJ, Kluin PM et al. Clinical course and pathologic features of conjunctival non–Hodgkin’s lymphoma. A report of six cases. Graefes. Arch. Clin. Exp. Ophthalmol. 1990; 228 (3): 246–251.

Cher L. Primary CNS Lymphoma. Cancer Forum. 1998; 22 (2): 138–140.

Connor JM. Problem in Lymphoma Management: Special Sites of Presentation // Oncology. 1998; 12 (2): 185–195.

Jensen OA, Johansen S, Kiss K. Intraocular T–cell lymphoma mimicking a ring melanoma. First manifestation of systemic disease. Report of a case and survey of the literature. Graefes. Arch. Clin. Exp. Ophthalmol. 1994; 232 (3): 148–152.

Roos DE, O'Brich PC, Crompton JL. Ocular involvement in primary central nervous system lymphoma: an ancreasing clinical problem? Australas. Radiol. 1993; 37 (4): 372–374.

Medeiros LJ, Harmon DC, Linggood RM, Harris NL. Immunohistologic featurs predict clinical behavior of orbital and conjunctival lymphoid infiltrates. Blood. 1989; 74: 2121–2129.

Неходжкинские лимфомы (НХЛ). Доступно: https://empendium.com/ru/chapter/B33.II.15.13..html

Armitage JO. Peripheral T-cell lymphoma. In: Canellos GP, Lister TA, Sklar JL, eds. The Lymphomas. Philadelphia: WB Saunders; 1998. 439-48 с.

Published

2022-11-15

How to Cite

1.
Malachkova N, Prus Y, Magdebura S. Non-Hodgkin B-cell MALT lymphoma of marginal zone of the upper eyelid. J.ophthalmol.(Ukraine) [Internet]. 2022 Nov. 15 [cited 2023 Feb. 5];(5):65-70. Available from: https://ojs.ozhurnal.com/index.php/files/article/view/102